Pak Fah Yeow International Limited (0239.HK)

HKD 2.27

(-1.3%)

Operating Income Summary of Pak Fah Yeow International Limited

  • Pak Fah Yeow International Limited's latest annual operating income in 2023 was 143.01 Million HKD , up 209.39% from previous year.
  • Pak Fah Yeow International Limited's latest quarterly operating income in 2024 Q2 was 60.88 Million HKD , down 0.0% from previous quarter.
  • Pak Fah Yeow International Limited reported an annual operating income of 46.22 Million HKD in 2022, up 2.68% from previous year.
  • Pak Fah Yeow International Limited reported an annual operating income of 45.01 Million HKD in 2021, up 69.58% from previous year.
  • Pak Fah Yeow International Limited reported a quarterly operating income of 143.01 Million HKD for 2023 FY, up 209.39% from previous quarter.
  • Pak Fah Yeow International Limited reported a quarterly operating income of 73.74 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Pak Fah Yeow International Limited (2023 - 1999)

Historical Annual Operating Income of Pak Fah Yeow International Limited (2023 - 1999)

Year Operating Income Operating Income Growth
2023 143.01 Million HKD 209.39%
2022 46.22 Million HKD 2.68%
2021 45.01 Million HKD 69.58%
2020 26.54 Million HKD -40.27%
2019 44.44 Million HKD 26.03%
2018 35.26 Million HKD -51.57%
2017 72.8 Million HKD -6.38%
2016 77.77 Million HKD -1.35%
2015 78.83 Million HKD 2.05%
2014 77.24 Million HKD 44.62%
2013 53.41 Million HKD 24.36%
2012 42.95 Million HKD 40.32%
2011 30.6 Million HKD -50.25%
2010 61.52 Million HKD -11.67%
2009 69.65 Million HKD 151.24%
2008 27.72 Million HKD -43.54%
2007 49.09 Million HKD -5.65%
2006 52.03 Million HKD 30.0%
2005 40.02 Million HKD -25.36%
2004 53.63 Million HKD 36.78%
2003 39.2 Million HKD 61.76%
2002 24.23 Million HKD 233.18%
2001 7.27 Million HKD -76.88%
2000 31.47 Million HKD -0.1%
1999 31.5 Million HKD 0.0%

Peer Operating Income Comparison of Pak Fah Yeow International Limited

Name Operating Income Operating Income Difference
Grand Pharmaceutical Group Limited 2.66 Billion HKD 94.63%
Extrawell Pharmaceutical Holdings Limited -8.16 Million HKD 1852.169%
Wai Yuen Tong Medicine Holdings Limited 40.88 Million HKD -249.834%
Qianhai Health Holdings Limited -52.18 Million HKD 374.059%
Lee's Pharmaceutical Holdings Limited 36.04 Million HKD -296.793%
Essex Bio-Technology Limited 310.32 Million HKD 53.916%
Tongfang Kontafarma Holdings Limited - HKD -Infinity%
PuraPharm Corporation Limited -66.04 Million HKD 316.534%
SSY Group Limited 1.63 Billion HKD 91.274%
JBM (Healthcare) Limited 174.2 Million HKD 17.906%
Jacobson Pharma Corporation Limited 333.12 Million HKD 57.07%
China Resources Pharmaceutical Group Limited 12.14 Billion HKD 98.823%